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Abstract
During postnatal development the heart undergoes a rapid and dramatic transition to adult function
through transcriptional and post-transcriptional mechanisms, including alternative splicing (AS).
Here we perform deep RNA-sequencing on RNA from cardiomyocytes and cardiac fibroblasts to
conduct a high-resolution analysis of transcriptome changes during postnatal mouse heart
development. We reveal extensive changes in gene expression and AS that occur primarily
between postnatal days 1 and 28. Cardiomyocytes and cardiac fibroblasts show reciprocal
regulation of gene expression reflecting differences in proliferative capacity, cell adhesion
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functions, and mitochondrial metabolism. We further demonstrate that AS plays a role in vesicular
trafficking and membrane organization, These AS transitions are enriched among targets of two
RNA-binding proteins, Celf1 and Mbnl1, which undergo developmentally regulated changes in
expression. Vesicular trafficking genes affected by AS during normal development (when Celf1 is
down-regulated) show a reversion to neonatal splicing patterns after Celf1 re-expression in adults.
Short-term Celf1 induction in adult animals results in disrupted transverse tubule organization and
calcium handling. These results identify potential roles for AS in multiple aspects of postnatal
heart maturation, including vesicular trafficking and intracellular membrane dynamics.
The heart is the first organ to form and function during vertebrate embryogenesis1. The first
four postnatal weeks involve a period of extensive physiological remodeling with dynamic
changes as the fetal heart adapts to birth and converts to adult function. This transition
occurs through transcriptional and post-transcriptional mechanisms, including coordinated
networks of alternative splicing (AS)1–4.
Human and rat hearts are composed of 66% cardiac fibroblasts (CF), 30% cardiomyocytes
(CM), and 4% endothelial and vascular smooth muscle cells5–7. Studies differ regarding
adult mouse heart composition. While Soonpaa et al. reported that CF account for 86% of
cells8, a recent analysis demonstrated a composition of 26% CF, 56% CM, and 18% non-
CM and non-CF9. However, CM comprise ~75% of the tissue volume in mammals7. CM
generate the contraction force and CF form the mechanical scaffold required for effective
pumping10. CM and CF communicate through multiple signaling mechanisms and through
extracellular-matrix (ECM)11. Other CF functions include response to cardiac injury12 and
electrical isolation of different regions of the cardiac conduction system13. By postnatal day
7 (PN7), CM lose proliferative capacity and heart size increases due to CM
hypertrophy14–15. Limited microarray analysis of mRNA expression in freshly isolated CM
and CF showed that while certain genes are highly expressed in CM, many growth factors,
cytokines, and ECM genes are more highly expressed in CF16. Overall, the published data
address a limited number of gene expression changes in CM and CF during development,
and notably, do not provide AS information.
High-throughput studies of AS and gene expression regulation have primarily focused on
differences between tissues, normal versus pathological conditions, or cultured cells. A
small set of reports have addressed AS and gene expression changes during normal
physiological transitions17–21. Development provides an outstanding opportunity to identify
coordinated AS regulation critical for physiological transitions from embryonic to adult
functions. Previously, we showed that genes that undergo AS regulation during heart
development produce transitions from embryonic to adult protein isoforms largely without
changes in overall transcript levels, presenting a new paradigm for understanding
developmentally regulated gene expression in heart3. Nearly half of the AS transitions
identified in mouse are conserved during post-hatch chicken heart development, suggesting
highly conserved functions for splicing-mediated isoform transitions3.
In the present study, we analyzed AS and gene expression transitions regulated during
postnatal mouse heart development using mRNA deep sequencing (RNA-seq)22. To gain
insight into the diversity of cell type-specific transitions, we performed RNA-seq using
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freshly isolated CF and CM from a developmental time course. The results revealed that
most gene expression and AS changes occurs within the first four weeks after birth, and that
CM and CF exhibit reciprocal transitions in expression of specific functional categories
(proliferation, cell adhesion, cytokines-chemotaxis, metabolism, transcription regulation).
Interestingly, we found that genes involved in vesicular trafficking and membrane
organization are regulated by AS during postnatal CM development. These AS changes are
enriched as targets of the CUGBP, ELAV-Like family (Celf) and Muscleblind-like (Mbnl)
RNA-binding protein families, both of which are involved in AS and are regulated during
postnatal heart development3,23–24. In the heart, vesicular trafficking-related AS transitions
likely impact ligand/growth factor uptake, ion channels dynamics, and/or postnatal
formation of the sarcoplasmic reticulum (SR) and transverse tubules (T-tubules), crucial
processes for excitation-contraction coupling (ECC) that are established by PN3025. We
show that re-expression of CELF1 in adults specifically in CM results in altered T-tubule
structure and mis-regulated calcium handling consistent with alterations associated with re-
expression of fetal splicing patterns.
RESULTS
Extensive transcriptome changes during postnatal development
RNA-seq was performed using RNA from mouse ventricles isolated at five time points:
E17, PN1, PN10, PN28, and adult (PN90). cDNA libraries were prepared after ribosomal
RNA (rRNA) depletion for 100 bp paired-end reads using the Illumina HiSeq2000. We
obtained >150 million read pairs per sample, >80% of which mapped the mouse genome
(Supplementary Table 1).
We identified 2,568 differentially expressed genes (≥2.0 fold, FDR 0.01, Supplementary
Material) between E17-adult: 747 were up-regulated and 1,821 down-regulated (Fig. 1a).
Analysis of mRNA isoforms whose percent spliced in (PSI)26 values changed ≥20%
(ΔPSI≥20%) between E17-adult identified 927 AS events, 190 alternative 3´ untranslated
regions (UTRs), and 210 alternative first exons (Fig. 1b). Postnatal AS transitions were
predominantly cassette exons (62%), while alternative 3´ and 5´ splice sites each represented
9%. We observed a relatively high proportion of transitions (20%) involving intron retention
with roughly equal proportions of events exhibiting increased inclusion or exclusion of the
variable regions during development (Fig. 1c–d).
Extensive remodeling within the first four weeks after birth
Gene ontology (GO) analysis of down-regulated genes between E17-adult in ventricles
showed a clear enrichment (p<1E-10) in categories related with cell cycle and DNA
replication (Fig. 2a-left). As ~75% of ventricular RNA originates from CM7, this is
consistent with the loss of CM proliferative activity by PN714,15. Up-regulated genes
between E17-adult showed enrichment in categories related to mitochondria, fatty acid
metabolism, and oxidation-reduction processes (Fig. 2a-right) consistent with increased
mitochondrial number and the metabolic switch from carbohydrates to fatty acids, a
hallmark of the fetal to adult CM metabolic transition27,28.
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Analysis of three time windows (E17-PN10, PN1-PN28, PN28-PN90) revealed that the
majority of gene expression transitions occurred before PN28 (Fig. 2b). Enrichment analysis
in each period showed that down-regulation of cell cycle related genes occurred before
PN28 (−log p dropped off after PN28) (Fig. 2c-left) in agreement with the loss of CM
proliferative capacity early after birth. Similarly, up-regulated genes related to mitochondria,
fatty acid metabolism, and oxidation-reduction were more enriched before PN28 (Fig. 2c-
right). In contrast, categories such as focal adhesion and ECM-receptor interaction were
more enriched after PN28 in down-regulated genes (-log p increased after PN28) (Fig. 2c-
left). Detailed analysis of individual cell cycle and ECM genes confirmed temporal
differences in down-regulation. The majority of ECM related genes maintained high mRNA
levels within the first ten days after birth, dropped off at PN28 and decreased further in
adults, while 81% of cell cycle genes were strongly down-regulated before PN10
(Supplementary Fig. 1a–b). The 3´ UTRs of down-regulated ECM- and cell cycle-related
genes were computationally analyzed for putative microRNA (miRNA) miR-15 and miR-29
seed sequences. While 41% of the down-regulated ECM genes were predicted to be miR-29
targets, 33% of the down-regulated cell cycle genes were predicted to be miR-15 targets.
These results suggest that a possible mechanism for the distinct patterns of cell cycle and
ECM down-regulation could involve miRNAs since these transcripts are well established
targets of developmentally up-regulated miRNAs such as miR-15 and miR-29 families29–32.
Celf1 loss correlates with increased expression of gene sets
To investigate a mechanism of up-regulation during postnatal development, we explored a
potential role for Celf1, an RNA-binding protein down-regulated ten-fold during the first
two weeks after birth3. Celf1 binds to GU-rich motifs within introns regulating AS3,33 and
within 3' UTRs promoting mRNA decay34,35. To identify genes that are responsive to Celf1
expression during postnatal development, we used previously described tetracycline-
inducible transgenic mice (TRECUGBP1/MHC) to induce human CELF1 expression in
CM33. RNA-seq was performed using ventricles of adult TRECUGBP1/MHC and control
(MHC) littermates after 12, 24, 72 hours or 7 days of induction. A high fraction (41%) of the
developmentally up-regulated genes was down-regulated within 72 hours of exogenous
CELF1 re-expression in adults (Fig. 2d-left). While a large number of genes are down-
regulated after CELF1 induction (5,499), the majority (93%) of them shows a relatively
small change (≤2.0 fold, after 72 hours). In contrast, a high fraction (78%) of the 306
overlapping genes (up-regulated during development and down-regulated by CELF1
expression) shows a fold change ≥2.5, suggestive of a physiological response.
Developmentally up-regulated genes responsive to CELF1 (the 306 genes) were enriched in
oxidation-reduction pathways, fatty acid metabolism, mitochondria, and sarcomere related
categories. By contrast, only 14% of developmentally down-regulated genes were affected
by CELF1 re-expression (Fig. 2d), suggesting that a percentage of the developmentally up-
regulated mRNAs are destabilized by CELF1. A high proportion of the developmentally
down-regulated genes overlapped with the down-regulated genes after CELF1 induction
(Fig. 2d, bottom right). However, CELF1 down-regulated genes show only 31% overlap
with developmental down-regulated genes compared to 41% overlap with developmentally
up-regulated genes suggesting that Celf1 postnatal down-regulation stabilizes a large subset
of mRNAs. It is also likely that there are secondary consequences to CELF1 re-expression
Giudice et al. Page 4
Nat Commun. Author manuscript; available in PMC 2014 October 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(such as effects on transcription factor expression) resulting in both positive and negative
effects on mRNA levels. To further investigate the potential CELF1 role in regulating
mRNA stability during postnatal development, we analyzed the 3´ UTRs of 58 genes in the
oxidation-reduction and mitochondria categories for CELF1-binding motifs (Supplementary
Fig. 1c–d). The GU-rich motif shown in Supplementary Fig. 1c was significantly enriched
(E=2.5E-05) and present in 24% of the analyzed 3´ UTRs. A similar GU-rich motif was
found by CLIPZ with a high level of enrichment (Supplementary Fig. 1d). CLIPZ and
MEME analysis also identified enrichment of polyA and GGA motifs (Supplementary Fig.
1d, and data not shown). These results suggest that postnatal Celf1 down-regulation
promotes up-regulation of genes within specific functional pathways through mRNA
stabilization.
Transcriptome changes in CM and CF during development
To identify cell-type specific transitions, we isolated CM and CF from ventricles of PN1–3,
PN28–30, and adult (PN60–67) animals. RNA was extracted from CM and CF cell
populations within three hours of animal sacrifice to reduce post-mortem and cell
manipulation effects. CF from all developmental stages and neonatal CM were isolated by
an enzymatic digestion/pre-plating method. Adult and PN30 CM were isolated by
Langendorff perfusion (see Methods). Morphology, binucleation (CM), and positive
immunostaining for alpha-actinin (CM) and vimentin (CF) from adult animals were
confirmed by confocal and differential interference contrast microscopy (DIC) (Fig. 3a).
Reverse transcription PCR (RT-PCR) analysis of cell-specific markers in adult CM and CF
demonstrated a high degree of purity (Fig. 3b). Analysis of cell-specific markers in RNA-
seq data confirmed these results demonstrating similar purity levels for early and late
postnatal stages (see below).
RNA-seq (paired-end 100 nt reads) was performed on CM and CF polyA-selected RNA
producing >160 million read pairs per sample with 85–90% mapping to the mouse genome
(Supplementary Table 1). Biological replicates generated highly reproducible results in
neonatal CF and CM populations with high Pearson coefficients (R) for both gene
expression (RCM=0.98, RCF=0.99) and AS (RCM=0.96, RCF=0.94). In addition, gene
expression from CM and ventricle RNA-seq data highly correlated (R=0.81) while CF-
ventricle correlation was low (R=0.33) (Supplementary Fig. 2a–c). These results are
consistent with the fact that ~75% of the ventricular volume is formed by CM7.
To evaluate CM and CF separation at all developmental stages, we used the fragments per
kilobase per million mapped (FPKM) to estimate “CM-enrichment” (CME) and “CF-
enrichment” (CFE) values defined as the ratios CMexpression/CFexpression and
CFexpression/CMexpression respectively16,36 (Fig. 3c). This analysis provided several
conclusions. First, while several CF-enriched transcripts showed constant ratios during
development, CM-enriched transcripts showed a dramatic increase in CME values from
PN1–3 to PN28. This reflects an active burst of CM maturation after birth compared to a
less robust change during CF maturation (see below). Second, PN1–3 CME values were ≥10
for CM-enriched transcripts in PN1–3 and much higher for PN30 and adult indicating highly
pure CM populations at all developmental stages. Third, the lower CFE values for some CF-
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enriched mRNAs at PN1–3 compared to PN30 and adult could reflect a low level of
contamination as well as incomplete cell maturation. To evaluate possible contamination of
the CF population with CM in PN1–3, we examined Nppa which is highly expressed in
neonatal CM28. We found Nppa to be highly enriched in CM compared to CF populations
and estimate contamination of CF preparations (PN1–3) with CM to be <2%.
Reciprocal gene expression transitions between CM and CF
RNA-seq revealed 3,064 down-regulated genes in CM and 1,645 in CF from PN1–3 to
adult. Up-regulated genes numbered 1,981 in CM and 928 in CF. Interestingly, >82% of the
differentially expressed genes in CM were not differentially expressed in CF (Fig. 3d).
Postnatal gene expression transitions in CM and CF showed a reciprocal regulation of
enriched functional categories such as mitochondrial metabolism, chemotaxis, cell adhesion,
and proliferation, among others (Fig. 3e, Supplementary Table 2). To validate reciprocal
expression at the level of individual genes, we analyzed expression of three previously
published CM-specific genes involved in mitochondrial metabolism. RNA-seq data from
CM and CF for Slc2a4 (solute carrier family 2, facilitated glucose), Cs (citrate synthase),
and Pdk2 (pyruvate dehydrogenase kinase 2) transcripts showed postnatal up-regulation for
CM and down-regulation for CF (Fig. 3f). The fold induction observed by RNA-seq in CM
for these metabolic transcripts was comparable to quantitative PCR data previously reported
in total mouse heart28.
AS transitions in ventricles occur mainly before PN28
We next focused on AS transitions during postnatal heart development. AS assayed by
either RNA-seq or RT-PCR was quantified as the PSI of the variable region and the change
in splicing is ∆PSI26. To validate postnatal transitions detected by RNA-seq in ventricular
RNA, we performed RT-PCR analysis of 36 events, 17 with ΔPSI≥20% predicted from
RNA-seq, 8 with ΔPSI≤-20%, and 11 with intermediate changes. A high Pearson correlation
(R=0.93) between ΔPSI values from RT-PCR and RNA-seq experiments demonstrated the
accuracy of our RNA-seq data for both strongly and weakly regulated transitions (Fig. 4a–b,
Supplementary Fig. 3, and Supplementary Table 3).
We identified 927 AS transitions during development (|ΔPSI|≥20%) in 773 genes, 82%
occurring in genes for which transcript levels changed less than 2-fold (Fig. 4c). These
results are consistent with previous evidence from a smaller set of AS transitions3.
Therefore, a substantial impact of AS during development occurs through changes in protein
isoform levels rather than total gene expression variations. As observed for gene expression
transitions, the majority of the developmental AS changes occurred before PN28 (Fig. 4d).
Temporal dynamics of AS transitions in CM and CF
RNA-seq revealed that during postnatal development more AS events changed in CM (809)
than in CF (326) between neonatal and adult stages (Fig. 5a). Six transitions were validated
in neonatal and adult CM and CF populations, showing high correlation (R=0.84) between
RT-PCR and RNA-seq ΔPSI values (Supplementary Fig. 2d–e). In both cell types the
majority were cassette exons (82–83%) and the rest were alternative 3´ splice sites (6%), 5´
splice sites (7–9%) and intron retention (3–4%). There was a slight preference for inclusion
Giudice et al. Page 6
Nat Commun. Author manuscript; available in PMC 2014 October 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
of the variable region in both CM (65%) and CF (59%) during development (Supplementary
Fig. 2f–g).
Consistent with the AS analysis from ventricular RNA, >90% of postnatal transitions in CM
occurred by PN30 (844 versus 78 after PN30). In CF, less than half of the postnatal
transitions occurred before PN28 (377 versus 175 after PN28) (Fig. 5a-left). These results
suggest that AS primarily impacts CM maturation during the first four weeks after birth
while in CF splicing changes are distributed throughout postnatal life. Gene expression
patterns showed a similar burst of expression before PN28–30 that was more pronounced in
CM than in CF (Fig. 5a-right).
More than half of the genes undergoing postnatal AS transitions in either CM (67%) or CF
(74%) did not change expression ≥2.0 fold and the majority of postnatal transitions were
specific to either CM or CF populations (Fig. 5b–c). Only 67 events were developmentally
regulated in both cell types, 82% of them (55 events) occurred in the same direction, and 12
events showed opposite transitions in CF and CM with a strong negative correlation (R=
−0.98) (Fig. 5d–e).
Taken together these data confirmed that, as in ventricles, AS transitions occur primarily by
PN28 in CM and are mainly cell-type specific.
Postnatal regulation of vesicular trafficking genes by AS
The AS transitions in ventricles (E17-adult) showed that vesicular trafficking, protein
localization-transport, endocytosis, membrane organization-invagination were the most
represented categories (p<5E-03) including the largest numbers of genes (10 to 27).
Analysis of three time windows (E17-PN1, PN1–PN28, and PN28-adult) revealed that
categories related to vesicular trafficking and membrane organization were enriched and
highly significant before PN28. In contrast, categories related to transcription regulation and
chromatin organization were predominant after PN28 (Fig. 6a). In general, GO analysis of
AS and differentially expressed genes showed little overlap, further suggesting
independence of AS and gene expression regulation (Fig. 2a, 2c, 3e, 6a–b).
Vesicular trafficking categories were also highly predominant during CM development (Fig.
6b) while transitions during CF development were enriched for other KEGG-pathways
(adherens junction, p=1E-02; actin-cytoskeleton regulation, p=5E-02; ECM-receptor
interaction, p=8E-02). Therefore, AS regulates different processes in each cell type.
Vesicular trafficking genes AS regulation by Celf1 and Mbnl1
Celf1 and Mbnl1 have been shown to regulate AS during mouse heart development3,37–38.
We used the RNA-seq data obtained from adult TRECUGBP1/MHC animals after 12, 24, 72
hours or 7 days of doxycycline induction and MHC littermates (72 hours on doxycycline) to
identify CELF1-responsive AS transitions. Published RNA-seq data from hearts of Mbnl1
knock-out mice (Mbnl1∆E3/∆E3)39 allowed the identification of Mbnl1-sensitive events
among postnatal AS transitions. From the 88 developmental transitions responsive to
CELF1 re-expression in adults, 71 (81%) reverted to neonatal patterns. Of the 62 Mbnl1-
sensitive transitions, 38 (61%) reverted to neonatal patterns in adult Mbnl1∆E3/∆E3 animals.
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Overall, 93 postnatal AS transitions (12%) were regulated by CELF1 and/or Mbnl1 and
more than half of them (57 events) were regulated by both (35 events antagonistically, 22
events in the same direction) (Fig. 6c–d, Supplementary Table 4).
Genes with postnatal AS transitions affected by CELF1 and/or Mbnl1 were enriched for
vesicular trafficking, endocytosis, and membrane organization-invagination processes (Fig.
6b). Reversion to neonatal splicing pattern in trafficking genes by CELF1 expression was
confirmed by RT-PCR analysis of 17 events (Fig. 7a–c, Supplementary Fig. 4, data not
shown). A high correlation was observed between RNA-seq and RT-PCR ΔPSI values and
between developmental change (ΔPSIadult-PN1) and reversion after CELF1 expression
(ΔPSIMHC-CELF1oe) (Fig. 7b–c). The vesicular trafficking genes regulated by AS during
development and responsive to CELF1 re-expression in adults are linked with each other
after testing networks connections using GeneMANIA software (Fig. 7d).
We analyzed the direct involvement of CELF1 in regulating AS during CM development by
performing a motif analysis within the up- and downstream flanking introns (300 bp) of the
exons regulated during development that responded to CELF1 re-expression in adults (88
events). GU rich motifs were enriched (p≤1E-08) in downstream regions of AS exons
(Supplementary Fig. 5a). Upstream flanking regions of AS exons were enriched in U or C
rich motifs (p=1E-14) when the variable regions were more skipped after CELF1 induction
and GU rich sequences (p≤1E-09) when the exons were more included in response to
CELF1 (Supplementary Fig. 5b). iCLIP-seq data are available for Celf1 in C2C12 muscle
cell differentiation40 and were used for evidence of direct binding of Celf1 to the 71
transcripts regulated by AS during heart development that show a reversion to the neonatal
pattern after CELF1 re-expression in adults. We evaluated the presence of iCLIP-tags within
the up- and/or downstream 500 bp of the intron sequences flanking the AS exons and
observed that 54% of them (38 out of 71) contain iCLIP-tags within these regions
(Supplementary Table 5) (Fisher test: 1.7E-11 compared with whole gene exon iCLIP
binding). When iCLIP-tags were evaluated for AS exons of vesicular trafficking genes we
found that 50% of them contain iCLIP-tags within 500 bp of their flanking regions, two
examples are shown in Supplementary Fig. 5c.
Taken together these results support the hypothesis that vesicular trafficking is regulated at
the splicing level during postnatal CM development and that CELF1 directly regulates a
substantial fraction of these transitions.
T-tubule and calcium release disruption by CELF1 induction
Membrane organization and vesicular trafficking are particularly dynamic during postnatal
CM development. The assembly of the excitation-contraction apparatus starts at birth and
ends within four weeks involving T-tubules invagination from the sarcolemma, SR
formation and vesicular trafficking of ion channels and adaptor proteins to specialized
membrane regions41,42. We hypothesized that the splicing transitions regulated by Celf1
play a role in assembly and maintenance of these structures. To test this hypothesis, we
determined the effect of CELF1 induction on adult T-tubule structure and function. CELF1
was re-expressed in adult mice for four days specifically in CM (Fig. 8a). CELF1-expressing
animals showed altered electro- and echocardiograms exhibiting lower fractional shortening,
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ejection fraction, and heart rate compared with MHC controls (Fig. 8b, Supplementary
Tables 6 and 7). Animals with higher exogenous CELF1 expression (#4) showed more
affected cardiac parameters than animals with lower exogenous CELF1 expression (#3). T-
tubules were stained and imaged in living CM (Fig. 8c) and T-tubule structure was studied
by three approaches. First, we delimited a rectangular region within the cell excluding nuclei
and we performed the Fast Fourier Transform (FFT), an algorithm to convert a function of
time/space into a frequency function and vice versa. With the FFT we obtained the
normalized T-tubule power by measuring the ratio between the pick power (first pick of the
FFT) and the baseline power. Normalized T-tubule power after FFT measures the global
regularity of the T-tubule network, and densities of transverse and longitudinal elements of
T-tubules41,43 (see Methods). CELF1-expressing CM showed lower T-tubule power than
MHC controls (Fig. 8d). Second, we quantified the average T-tubule area within CM28. T-
tubule area is defined as the percentage of the area containing T-tubule staining28 (see
Methods). While MHC mice showed 18±3% (n=12 cells) of CM area as T-tubules, CELF1-
expressing CM showed 9±1% (n=16 cells) (p=0.02) (Fig. 8e). When analyzed separately,
CM from mice expressing higher CELF1 levels showed less T-tubule area compared to mice
expressing lower CELF1 levels (mouse #3: 12±1%, mouse #4: 7±1%). Third, we devised an
approach to estimate the proportion of individual cells with disorganized T-tubule structure
(T-tubule irregularity) (see Methods). Control CM showed lower T-tubule irregularity
(10±2%; n=13 cells) than CELF1-expressing CM (36±5%; n=16 cells) (p=4E-05) (Fig. 8f).
Next, we addressed whether T-tubule disruption correlated with defective calcium release.
Calcium spark frequency was higher in CELF1-expressing CM than in controls (7.9±1.9
versus 1.4±0.4 sparks (100 µm)−1 sec−1; n=11 cells each genotype; p=6E-03) (Fig. 8g).
Similarly to T-tubule disruption, CELF1-expressing mouse #4 (sickest) presented more
frequent calcium sparks than CM from mouse #3 (healthiest) (10±3 versus 6±2 sparks (100
µm) −1 sec−1). Spontaneous calcium sparks are due to the opening rate of ryanodine
receptors and frequency changes reflect alterations in ryanodine receptor itself, its
association with other proteins, receptor cluster spatial organization, inter-cluster distance,
and/or calcium content in the SR44. Overall, T-tubule organization observed in CELF1-
expressing CM resembles PN10–15 structure41, suggesting reversion to earlier
developmental stages.
DISCUSSION
We used RNA-seq to identify transcriptome dynamics from late embryonic to adult mouse
heart development. While multiple studies have focused on specific genes or gene sets
during heart development, this study presents a global analysis of postnatal gene expression
and AS transitions in ventricles and freshly isolated CM and CF. The strong correlations of
global postnatal changes between CM and ventricles flash-frozen immediately after sacrifice
supports our contention that transcriptome transitions identified in isolated CM and CF are
largely representative of those occurring in tissue. The similarity between ventricle and CM
RNA-seq data is particularly striking given that CM RNA was polyA selected and
ventricular RNA was prepared by rRNA depletion. Overall, we revealed novel insight into
strikingly different postnatal gene expression and AS transitions that occur in distinct but
highly interacting cell populations within ventricles.
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The largest transitions between E17-adult occur before PN28, a period in which extensive
physiological changes take place as the fetal heart adapts to birth and converts to adult
function1,2. In CM, 90% of the gene expression and AS transitions occur before PN28 while
in CF nearly 50% occur later. Gene expression and AS follow the same patterns in each cell
type suggesting a general tendency for CM to set an adult pattern of gene output within the
first four weeks after birth while CF undergo a more gradual transition. We hypothesize that
this reflects the maturation required in CM in response to cell proliferation loss, cellular
hypertrophy, and rapidly increasing workload during the first four weeks after birth. By
contrast, CF would not require as dramatic physiological maturation.
Our data reveal a high level of specificity in CM and CF gene expression and a reciprocal
expression changes in the two cell types. While genes involved in critical CM functions such
as mitochondrial metabolism are developmentally up-regulated, they are down-regulated in
CF. Similarly, focal adhesions and chemotaxis genes are up-regulated during CF
development but down-regulated in CM.
We examined potential mechanisms for post-transcriptional regulation of gene expression
during development and identified a likely role for the 10-fold down-regulation of Celf1 in
the developmentally up-regulation of a subset of genes. While our previous analysis focused
on the Celf1 role in a set of splicing transitions3, Celf1 has also been shown to destabilize
mRNAs by binding to GU-rich motifs within 3´ UTRs34,35. We showed that 41% of the
genes normally up-regulated during development were down-regulated upon CELF1
induction and from those GU-rich motifs are enriched in 3´ UTRs of mitochondrial
metabolism genes. Therefore, our results implicate Celf1 in coordinated up-regulation of
genes involved in the postnatal metabolic transition of CM.
Consistent with our previous smaller scale study3, the majority of AS transitions detected
during postnatal heart development occurs without changes in total gene output, indicating
that protein isoform switches are important regulatory components during postnatal
development. Categories highly regulated by AS in heart, specifically in CM, are vesicular
trafficking, endocytosis, membrane organization-invagination. A link between trafficking
and AS is novel although several individual AS events in trafficking genes (e.g., Snap25,
Dab2, Mdm2) have been reported45,46. Additionally, categories relevant to trafficking were
enriched among genes modulated by AS by CELF1 and Mbnl1 suggesting that these
developmentally regulated RNA-binding proteins play a role in vesicle mediated transport
and membrane remodeling in CM.
Membrane remodeling and endocytosis are crucial in eukaryotic cells for a variety of
functions, some of which are cell type specific47. Recently, it was reported that AS impacts
endocytosis during brain development, suggesting that vesicular trafficking functions are
coordinated by AS21. Our results are similar in heart and the impact of vesicular trafficking
on cardiac functions is not known. Although many differences exist between heart and brain,
parallels between neuroscience and cardiac fields are growing, particularly with regard to
ion channels and vesicular trafficking processes48.
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We hypothesize several non-exclusive scenarios for vesicular trafficking roles during
postnatal heart development. First, AS regulation of vesicle-mediated transport could reflect
changes in ligand/growth factor uptake during development. Second, after PN7, CM stop
dividing and undergo cellular hypertrophy14,15. The most rapid increase in CM volume
occurs between PN4-PN20, after which CM volume increases only slightly49. Therefore,
cells must maintain the appropriate internalization-recycling balance while membrane
exposure to the extracellular environment is rapidly increasing. Third, vesicular trafficking
regulation by AS could control the dynamics of ion channel production and localization. Ion
channels are continuously formed, trafficked within vesicles for insertion and anchoring to
specific sub-regions of the plasma membrane, and removed for degradation or recycling. Ion
channel function is, therefore, dependent in part on surface density which is tightly regulated
by vesicular trafficking. The last scenario is supported by our analysis of T-tubule
organization and function after CELF1 re-expression in adults. Maturation and assembly of
SR and T-tubules in CM occur within the three-four weeks after birth41 producing the
machinery for ECC. These maturation processes involve extensive cell architecture
transitions, including membrane re-organization and vesicular-mediated protein transport.
Membrane invagination and vesicular trafficking is regulated by AS during postnatal
development and this may impact CM functions such as ECC and uptake, distribution, and
recycling of key molecules (ion channels, growth factors, receptors). Importantly, both up
regulation of CELF1 and loss of MBNL1 function are involved in the pathogenic
mechanisms of myotonic dystrophy type 1 (DM1) in which the best characterized molecular
feature is expression of fetal AS splicing patterns50. The alterations in T-tubule structure and
function we demonstrated strongly correlate with the finding that eighty percent of
individuals with DM1 exhibit cardiac arrhythmias51.
METHODS
Materials
Cell culture reagents were obtained from GIBCO, Life Technologies. Liberase TH Research
Grade and Collagenase/Dispase enzymes were from Roche Applied Science.
Animals
Ventricles, CM and CF were isolated from FvB wild type mice. TRECUGBP1/Myh6-rtTA
(TRECUGBP1/MHC) mice were used for human CELF1 over-expression in CM
(tetracycline-inducible) as described3,33. Bitransgenic and Myh6-rtTA (MHC) control adult
animals were fed 2 g/Kg doxycycline (BioServ) for 12, 24, 72 hours and 7 days (RNA-seq),
8 days (RT-PCR), or 4 days (T-tubule/calcium experiments). We followed NIH Guidelines
for use and care of laboratory animals approved by BCM Institutional Animal Care and Use
Committee.
Ventricle heart isolation
Animals were anesthetized and after cervical dislocation (older than PN10) or decapitation
(neonatal) hearts were removed. Blood and atria were removed; ventricles were frozen in
liquid nitrogen or freshly used for CM and CF isolation.
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CF and CM isolation
PN28 and adult CF isolation by pre-plating method. Minced ventricles were digested in
Dulbecco’s modified Eagle’s medium (DMEM) containing 0.1 U/ml Collagenase, 0.8 U/ml
Dispase, and 0.1% EDTA-free Tripsin for 10 min at 37°C (with stirring). After
sedimentation the remaining tissue was similarly digested for 10 min. The suspension was
centrifuged for 5 min at 3,000 × g, cells were resuspended in Minimum Essential Medium α
(MEM-α) supplemented with 10% fetal bovine serum (FBS) and kept on ice. This
procedure was repeated three to four times, cells were centrifuged for 5 min at 3,000 × g, the
pellet was resuspended in MEM-α/20% FBS and cells were seeded on cell culture dishes.
Cells were plated for 2 hours at 37°C under 5% CO2. Adherent cells were washed ten times
with PBS and RNA was immediately extracted. Neonatal CF and CM isolation. The
neonatal CM isolation kit (Cellutron Life Technology) was used with 20–35 ventricles
accordingly to manufacturer´s protocols. PN30 and adult CM isolation by Langendorff
perfusion. The heart was removed with the lungs without touching the heart, rinsed in Ca2+
free Tyrode´s solution (140 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 10 mM Glucose, 5 mM
HEPES pH 7.4) and cleaned from fat tissue. The heart was cannulated through the aorta and
perfused on a Langendorff apparatus with Ca2+ free Tyrode´s solution for 3–5 min, then
with Ca2+ free Tyrode´s solution containing 20 µg/ml (0.104 Wünsch units/ml) Liberase for
~15–25 min at 37°C and then with KB solution (90 mM KCl, 30 mM K2HPO4, 5 mM
MgSO4, 5 mM pyruvic acid, 5 mM β-hydroxybutyric acid, 5 mM creatinine, 20 mM taurine,
10 mM glucose, 0.5 mM EGTA, 5 mM HEPES pH 7.2) to wash out the enzyme. Atria were
removed, the heart was minced in KB solution, cells were gently pipeted up and down (on
ice) and filtered through Nylon mesh 210 µm open 155 µm thread, 24"×12" mash
(Smallparts inc). The sample was centrifuged for 5 min at 3,000 × g and RNA was
immediately extracted, or fresh CM were used for T-tubule experiments or
immunofluorescences, or were frozen in liquid nitrogen for Western blot assays.
RNA extraction
RNeasy fibrous tissue mini-kit (ventricles and CM) and RNeasy micro-kit (CF) were used
(QIAGEN).
RNA-seq analysis of CM and CF during development
RNA-seq samples showed the following parameters: A260nm/A280nm≥1.8, A260nm/
A230nm≥1.4, r28S:16S≥1.5, and RNA integrated number (RIN)≥8.6. Illumina TruSeq RNA
sample preparation protocols were used for CM (PN1–2, PN1, PN30, and PN67) and CF
(PN1–3, PN1–2, PN28, and PN60). Briefly, a double-stranded DNA library was created
using 1 µg total RNA. First, cDNA was created using the fragmented 3’ poly(A) selected
portion of total RNA and random primers. Libraries were generated from the cDNA by blunt
ending the fragments, attaching an adenosine to the 3’ end and finally ligating unique
adapters to the ends. The ligated products were amplified by PCR (15 cycles). Libraries
were quantified using the NanoDrop spectrophotometer and fragment size assessed with the
Agilent Bioanalyzer. A qPCR was performed on the libraries to determine the concentration
of adapter ligated fragments using a Bio-Rad iCycler iQ Real-Time PCR Detection System
and a KAPA Library Quant Kit. Using the concentration from the Bio-Rad qPCR, 11 pM
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library was loaded onto a flow-cell and amplified by bridge amplification using the Illumina
cBot equipment. A paired-end 100 cycle run was used to sequence the flow-cell on a HiSeq
Sequencing System.
RNA-seq
Illumina TruSeq protocols were used for wild type CM (PN1–2, PN1, PN30, and PN67) and
CF (PN1–3, PN1–2, PN28, and PN60), and ventricles from TRECUGBP1/MHC or MHC
animals (n=3 animals each time point). For developmental ventricle analysis, RNA was
rRNA depleted and libraries were prepared by Ribo-Zero Magnetic Gold and ScriptSeq-v2
RNA-seq library preparation kits (Epicentre Biotechnologies). Briefly total RNA (2 µg)
from ventricles of E17, PN1, PN10, PN28, and PN90 (adult) animals was rRNA depleted
using the Ribo-Zero Magnetic Gold Kit following manufacturer protocols. The rRNA-
reduced samples (~30 ng) were fragmented and primed with random hexamers containing a
5’-tagging sequence for RT priming. The 5’-tagged first strand cDNA was then generated.
During the second strand cDNA generation the RNA templates were removed leaving the
5’-tagged strand. Terminal-tagging oligos (TTO) were annealed to the 5’-tagged strand and
terminal-tagging oligos were blocked at the 3’ end preventing the synthesis of a secondary
strand. Resulting cDNA strand was single-stranded and tagged at both ends. The di-tagged
cDNA was purified using Agencourt AMPure XP system (Beckman Coulter). Single-
stranded cDNA generated for each sample was used for library construction. By PCR
amplification (10 cycles), the second cDNA strand was generated and the Illumina adapter
sequences were added simultaneously to the single-stranded di-tagged cDNA fragments.
Illumina sequencing libraries were purified using Agencourt AMPure XP system. Libraries
were validated on an Agilent Bio-analyzer High Sensitivity DNA chip checking the purity of
the sample and the size of the insert. Libraries were within 150–2000 bp on the
electropherogram. A second round of purification using Agencourt AMPure XP system was
required for removal of primer-dimer and adapter-dimer contamination. Libraries were
quantified using KAPA SYBR Fast qPCR kit from KAPA Biosystem. Libraries were diluted
to 2 nM (based on cT values), alkali denatured for 5 min, diluted to a final concentration of
11 pM, and dispensed into thin-walled PCR tubes to be loaded into the Illumina cBot.
Clusters were generated on the flow-cell by PCR with the Illumina cluster generation kit.
The flow-cell containing clustered libraries were loaded on the Illumina HiSeq instrument
along with the kitted sequencing reagents for a PE 100 bp run. During each sequencing
cycle, a dye-terminated nucleotide was incorporated into the single-stranded DNA strand
and fluorescence was monitored. Fluorescent dye was cleaved to allow next nucleotide
incorporation. CASAVA software converted the fluorescence measurements into sequence
files.
Computational processing of RNA-seq data from wild type CM, CF, and ventricles
RNA-seq Alignment. Paired-end RNA-seq reads were aligned to the mouse genome (mm9)
using TopHat 2.0.552. Differentially expressed gene analysis and FPKM. RSEM53 was used
to count the number of fragments mapped into Ensembl gene models, followed by edgeR54
to call differentially expressed genes with false discovery rate less than 0.01. The gene
expression was quantified by FPKM55. Differential AS events. Based on Ensembl 65 gene
model, SpliceTrap56 was employed to identify differential exon skipping, intron retention
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events, alternative 5’ or 3´splice site. AS was quantified by the percentage of mRNAs that
contain an alternative region as PSI value. The events with PSI changes between two
conditions |ΔPSI|≥20% were called differential splicing events.
Computational processing of RNA-seq data from CELF1 over- expressing and control
animals
Estimation of gene and isoform expression levels was performed similarly to previously
described39. Briefly, reads were mapped to the mouse genome (mm9) and a database of
splice junctions using the Bowtie tool57. Gene expression. Gene expression was measured as
following: i) the number of reads mapping to constitutive exons for each gene was
measured, ii) that measurement was divided by the number of kilobases of constitutive exon
model per million uniquely mapped reads. AS events. Isoform levels and Bayes factors were
measured by MISO58 (single end mode).
Bioinformatic analysis of 3´ UTRs
The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.759–60
was used for GO analysis considering p≤0.05 significant. miRNA prediction analysis was
performed using TargetScan (http://www.targetscan.org/) and motif analysis with CLIPZ
(SIB) and MEME version 4.9.061 (motif>6–18 bp) softwares. The E-value (MEME) is the
enrichment of a motif based on its log likelihood ratio, width, sites, back-ground
frequencies, and the training set size. The p-value of a site is computed from the the match
score of the site with the position specific scoring matrix for the motif. The p-value gives the
probability of a random string (generated from the background letter frequencies) having the
same match score or higher. Gene network of AS genes involved in vesicular traffic,
developmentally regulated, and sensitive to CELF1 induction was performed using
GeneMANIA62.
Bioinformatic analysis of AS events
The analysis involved the 88 developmental transitions responsive to CELF1 re-expression
in adults. The 300 nt upstream and downstream of the alternative spliced exons were used
for de novo motif analysis, excluding the last 30 nt of the upstream intron and first 9 nt of
the downstream intron of the alternative exons which contain the conserved 5’ and 3’ splice
sites, respectively. Then motif analysis tool HOMER63 (v4.3) was employed for RNA motif
analysis with the background sequences generated by first-order Markov model whose
parameters were estimated based on hg19.
Celf1 HITS-Clip data analysis
C2C12 Celf1 HITS-CLIP data was downloaded from European Nucleotide Archive (ENA;
accession code ERP000789)64. As described by authors64, the 4-bp tags were trimmed and
sequences composed primarily of Illumina adapter were removed. The pre-processed reads
were mapped to the mouse genome (mm9) using the alignment tool Bowtie57 with allowed
2-mismatch. Finally, reads with identical 5’ starts were further collapsed into a single read to
avoid potential PCR duplicates effects and only uniquely mapped reads were kept as final
Celf1 binding tags.
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AS validations by RT-PCR
RT-PCR were performed (High Capacity cDNA RT Kit, Applied Biosystems; and GoTaq
DNA Polymerase, Promega) in biological duplicates and products were analyzed by 6%
PAGE. PCR reactions involved the following steps: i) 95°C for 3 min, ii) 20–27 cycles of
95°C for 30 sec, 58°C for 30 sec, and 72°C for 30 sec, iii) 72°C for 7 min, iv) 25°C for 5
min. RNA-seq data were used to design primers annealing in the constitutive flanking exons
of the AS region. Sequences of the primers (SIGMA) used for validation in ventricles are
shown in Supplementary Table 8.Sequences of the primers (SIGMA) used for validation of
AS events on vesicular trafficking related genes are shown in Supplementary Table 9.
Densitometry measurements were performed using Kodak Gel logic 2200 and Molecular
Imaging Software. Percent spliced in (PSI)26 was calculated by densitometry following
equation (1).
equation (1)
Analysis of CM and CF markers by RT-PCR
RT-PCR assays were performed using the following primers (SIGMA): Vimentin-F (5´-
tgaaggaagagatggctcgt-3´), Vimentin-R (5´-ttgagtgggtgtcaaccaga-3´), Ddr2-F (5´-
caagatcatgtctcggctca-3´), Ddr2-R (5´-gccctggatccggtagtaat-3´), Nkx2.5-F (5´-
aagcaacagcggtacctgtc-3´), Nkx2.5-R (5´-gggtaggcgttgtagccata-3´), Tnnt2-F (5´-
cggaagagtgggaagagaca-3´), Tnnt2-R (5´-ttcccacgagttttggagac-3´), mGadph-F (5´-
cgtcccgtagacaaaatggt-3´) and mGadph-R (5´-ttgatggcaacaatctccac-3´). PCR reactions
involved the following steps: i) 95°C for 75 sec, ii) 20–27 cycles of 95°C for 45 sec, 57°C
for 45 sec, and 72°C for 1 min, iii) 72°C for 10 min, iv) 25°C for 5 min. PCR products were
analyzed by 6% PAGE.
Immunofluorescence
After adult CM and CF isolation, cells were seeded onto coverslips overnight (CM) or for 70
hours (CF). Coverslips were pre-coated with 20 µg/ml laminin for 1 hour at 37°C for CM.
Cells were fixed in 3.7% paraformaldehyde on ice for 20 min, blocked with PBS/0.3%
TritonX-100/1% bovine serum albumin (BSA) for 1 hour at 37°C, and incubated overnight
at 4°C with primary antibodies (rabbit monoclonal anti-vimentin (D21H3) (Cell Signaling,
#5741) (1:100) or mouse monoclonal (clone BM-75.2) anti-alpha-actinin (SIGMA, #A5044)
(1:50)). After washes samples were incubated with secondary antibodies conjugated with
Alexa-fluor-488 (Invitrogen) (1:500) for 1 hour at 37°C, washed, stained with 2 µM DAPI
for 5 min, and mounted (Slow Fade Gold Antifade Reagent, Invitrogen). Confocal
microscopy was performed with a Nikon A1-Rs inverted laser scanning microscope with a
40× Plan-Fluor/1.3 NA oil-immersion objective. Excitation: argon multi-line laser at 488 nm
(Alexa-fluor-488) or a 404 nm diode at 38 mW (DAPI). Emission filters: band-pass 525/50
nm (Alexa-fluor-488), band-pass 450/50 nm (DAPI). Confocal images were processed with
ImageJ. Background was subtracted and a median filter was applied (radius=1 pixel) for
presentation.
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T-tubules analysis
Isolated CM (adult TRECUGBP1/MHC or MHC doxycycline fed, n= 2 animals each) were
stained with 10 µM Di-8-ANEPPS (Invitrogen, #D3167) in KB-solution for 15 min, washed
and imaged by confocal microscopy (Zeiss LSM-510 microscope, 40× oil-immersion
objective). Excitation: argon multi-line laser, 488 nm. Emission filter: long-pass 505 nm.
Quantifications were performed using ImageJ: 1) a region of interested was selected
covering longitudinally the CM avoiding the nuclei, Fast Fourier Transform (FFT) was
obtained, power spectrum was computed and normalized (normalized T-tubule power)41; 2)
a threshold (MaxEntropy) was applied (ImageJ), cell interior was manually delimitated
(excluding plasma membrane), areas with green signal were summed within the threshold,
and normalized to the total area (T-tubule area); 3) CM from MHC animals showed 4–6 T-
tubules (10 µm)−1 (ImageJ), therefore, regions with 4–6 T-tubules (10 µm)−1 were
considered “regular-regions” otherwise “irregular-regions”. Three lines were drawn along
each CM, plots were obtained, normalized to its maximum, a cut off (15 units above the
baseline) was determined and each line was analyzed by the number of picks (T-tubules)
above the cut-off (between 0–10, 5–15, 10–20, 15–25 µm, etc) computing the “regular-
regions” and the “irregular-regions” (in µm). For each CM, the total length of the three lines
and the total “irregular-regions” were summed and T-tubule irregularity was calculated.
Calcium sparks analysis
The same samples were incubated with 3.5 µM Fluo-4-acetoxymethyl ester (Invitrogen,
#F14201) in Tyrode´s solution (1.8 mM Ca2+) (1 hour, room temperature), washed (15 min)
and transferred to a chamber containing parallel platinum electrodes. Fluorescence images
were recorded after pacing (10 V, 0.5 msec) from CM showing clear striation and normal
contractility. Sparks were analyzed using SparkMaster plugin (ImageJ).
Western blots
After perfusion, a portion of the ventricles from TRECUGBP1/MHC or MHC control
animals were lysed in HEPES-sucrose buffer (10 mM HEPES pH 7.4, 0.32 M sucrose, 1
mM EDTA, and proteases inhibitors) using Bullet blender (Next Advance) equipment and
SDS was added (final concentration: 1% SDS). Samples were sonicated (3 min at 75 V: 30
sec ON and 30 sec OFF) and centrifuged for 10 min at 14,000 r.p.m at 4°C. Supernatants
were transferred to new tubes and protein concentration was estimated with Pierce BCA
protein assay kit (Thermo Scientific). Samples were diluted in loading buffer (100 mM Tris-
HCl pH 6.8, 4% SDS, 0.2% Bromophenol blue, 20% glycerol, 200 mM β-mercaptoethanol),
boiled for 5 min, and total proteins (40 µg) were assayed by 10% SDS-PAGE. After transfer,
membranes were blocked in 5% non-fat dried milk/0.1% Tween-TBS buffer (TTBS) for 1
hour, washed and incubated overnight at 4°C with primary antibodies diluted in 5% milk/
TTBS: mouse monoclonal anti-CUG-BP1, clone 3B1 (Milipore, #05–621) (1:1,000), rabbit
polyclonal anti-sarcomeric alpha actinin (Abcam, #ab72592) (1:2,000). The following day,
membranes were incubated with secondary antibodies (1:5,000) for 1 hour at room
temperature: peroxidase-conjugated goat anti-mouse IgG light chain specific (Jackson
Immunoresearch, #115-035-174), goat anti-rabbit IgG horseradish peroxidase-conjugated
(Invitrogen, # 621234). Flag-tag was detected by monoclonal anti-FLAG M2 peroxidase
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(Sigma, #A8592) (1:1,000; 1 hour at room temperature). Super Signal West Pico
Chemiluminiscent Substrate kit (Thermo Scientific) was used for developing.
ECG and echocardiogram recording
Echocardiograms were performed using a Vevo 770 Ultrasound equipment with a 707B
probe for the cardiac analysis. The animals were sedated with 2% isoflurane for imaging.
The m-mode images were analyzed for data acquisition using the Vevo analysis package.
The ECG's were recorded using a Mouse Monitor made by Indus Instruments. Mice were
lightly anesthetized using 1.5% isoflurane and the paws were taped to the ECG leads. ECGs
were recorded for leads I, II, and III for each animal and analyzed. Both ECGs and
ultrasounds were performed in the Mouse Phenotyping Core at BCM.
Statistic
Results were expressed as the mean±s.e.m, p-values were estimated using Student´s T-test
(two tails), p≤0.05 was considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Extensive gene expression and RNA processing changes occur during heart
development
a–b. Differentially expressed genes (a) and alternative RNA processing between E17-adult
(b). c. AS events categorized by pattern. d. Proportion of skipping/inclusion of the AS
regions. AS: alternative splicing.
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Figure 2. Gene expression regulation occurs primarily before PN28
a. GO analysis (KEGG-pathways) of down- and up-regulated genes between E17-adult
(ventricles). b. Differentially expressed genes between E17-PN10, PN1–PN28, and PN28–
PN90 (ventricles). c. Significance of KEGG-pathways (−log p) were plotted against time
windows for specific categories. d. Venn diagrams with developmentally regulated genes
and those regulated after CELF1 re-expression on adult mice (RNA-seq data). GO analysis
of the intersected genes (summary). ECM: extracellular-matrix.
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Figure 3. Reciprocal gene expression transitions between CM and CF
a. Isolated adult ventricular CM and CF stained with anti-vimentin or anti-alpha-actinin.
Scale bars: 10 µm. b. RT-PCR assays of CF (Vim, Ddr2) and CM (Tnnt2, Nkx2.5) markers
on RNA from adult ventricles, CM and CF. Experiments were repeated with at least 3
independent samples. c. CF enrichment (CFE) for CF-enriched transcripts (blue) and CM
enrichment (CME) for CM-enriched transcripts (red) calculated from RNA-seq data. d.
Postnatal gene expression transitions in CM and CF (PN1–3 versus adult) by RNA-seq. e.
GO analysis of down- and up-regulated genes in CM and CF (Supplementary Table 2). f.
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Postnatal expression of three metabolic genes (RNA-seq data) showing reciprocal CM-CF
regulation. bp: base pairs. FPKM: fragments per kilobase per million mapped.
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Figure 4. Extensive postnatal AS transitions occur primarily without changes in gene expression
a. RNA-seq data (UCSC browser) and RT-PCR assays (n=2 biological replicates) for AS
events developmentally regulated (+ex: exon included; −ex: exon skipped). See
Supplementary Fig. 3, and Supplementary Table 3. b. Correlation between RNA-seq and
RT-PCR ΔPSI values. c. Genes undergoing postnatal AS transitions (|ΔPSI|≥20%) were
intersected with differentially expressed (DE) genes in ventricles (E17-adult). d. AS
transitions (|ΔPSI|≥20%; E17-adult) were plotted comparing their change between E17-
PN28 (red) and PN28-adult (green). Diagonal line: no difference between time points. Dots
above/below the diagonal: increased/decreased inclusion. AS: alternative splicing. bp: base
pairs. PSI: percent spliced in.
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Figure 5. Postnatal gene expression and AS transitions in CM and CF
a. AS transitions (|ΔPSI|≥20%) and gene expression changes in CM and CF. b. Genes
developmentally regulated by splicing (|ΔPSI|≥20%) in CM and CF were intersected with
differentially expressed (DE) genes (PN1–3 versus PN28–30). c. Postnatal AS transitions
(between PN1–3 and adult) specifically in CM, CF or both. d. Analysis of the 67 events
regulated in CF and CM. e. Three postnatal AS transitions occurring in opposite directions
in CM and CF. AS: alternative splicing. PSI: percent spliced in.
Giudice et al. Page 26
Nat Commun. Author manuscript; available in PMC 2014 October 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6. Vesicular trafficking genes are regulated by AS during development
a. GO analysis on AS genes (|ΔPSI|≥20%) in three time windows: E17-PN1, PN1–PN28,
PN28-adult (ventricles). b. KEGG-pathway analysis on AS genes detected by RNA-seq
during wild type CM development (|ΔPSI|≥20%), in adult CELF1-expressing hearts (CELF1
oe) and adult Mbnl1∆E3/∆E3 hearts (|ΔPSI|≥10%). c. AS transitions (|ΔPSI|≥20%) during CM
development (between PN1–3 and adult): regulation by Mbnl1 and/or CELF1. d. The 57
events regulated by Mbnl1 and CELF1 were analyzed in terms of antagonistic/not-
antagonistic effects (Supplementary Table 4). AS: alternative splicing.
Giudice et al. Page 27
Nat Commun. Author manuscript; available in PMC 2014 October 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7. Vesicular trafficking genes revert to neonatal splicing patterns after CELF1 re-
expression in adult hearts
a. RT-PCR (ventricles) of vesicular trafficking AS events during development and in
CELF1-expressing hearts. Bar graphs: mean±s.e.m (n=2 biological replicates). b.
Correlation between RNA-seq and RT-PCR data in vesicular trafficking genes (PN1-adult).
c. Correlation between developmental transitions in vesicular trafficking genes and reversion
after CELF1 re-expression in adults (RT-PCR). d. Network of vesicular trafficking genes
developmentally regulated by splicing and responsive to CELF1 (black circles). Grey
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circles: linking-genes. bp: base pairs. CELF1 oe: TRECUGBP1/MHC animals. MHC:
control animals. PSI: percent spliced in.
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Figure 8. T-tubule disorganization after CELF1 re-expression in adults
a. Western blot analysis from adult hearts after CELF1 induction. b. Fractional shortening
was measured in MHC (n=6 animals) and TRECUGBP1/MHC mice (n=3 animals) given
doxycycline (four days). Results are expressed as the mean±s.e.m. c. Confocal imaging of
T-tubules on living CM from MHC (#1–2; n= 2 animals) and CELF1-expressing (#3–4, n= 2
animals) mice. Scale bars: 10 µm. Third row: fluorescence plot over the line (first row). d–g.
T-tubule and calcium spark analysis: normalized T-tubule power (d) (n=13 cells for MHC
animals, n=16 cells for TRCUGBP1/MHC animals), T-tubule area (e) (n=12 cells for MHC
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animals, n=16 cells for TRCUGBP1/MHC animals), T-tubule irregularity (f) (n=13 cells for
MHC animals, n=16 cells for TRCUGBP1/MHC animals), calcium spark frequency (g)
(n=11 cells for each genotype). Asterisks show statistical differences (p≤0.05). Results are
expressed as the mean±s.e.m. CELF1 oe: TRECUGBP1/MHC animals. MHC: controls.
FFT: Fast Fourier Transform T-tubules: transverse tubules.
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